Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Bill who wrote (865896)	6/17/2015 4:01:04 PM
From: joseffy	Read Replies (1) \| Respond to of 1577562

Drugs.

To: Bill who wrote (865896)	6/17/2015 4:02:09 PM
From: joseffy	Respond to of 1577562

Limits to the Left’s Subjectivism? (Rachel Dolezal)... ........................................................................................................ American Spectator ^ \| George Neumayr The Rachel Dolezal story has put the Left in an awkward spot. An obviously white woman who has long presented herself to the world as black, Dolezal is testing the Left’s commitment to its own radical subjectivism. Frustrated by comparisons of Dolezal to the transgenderism they embrace, many liberals have declared the two cases completely different. But they have failed to show one, at least not a substantial philosophical difference. In both cases, a human being seeks to erase an immutable trait in order to assert a “self-definition” that exists in the mind, not the body. If humans have a right to define the “authentic self” without regard to their given human nature, why should that right be restricted to one fixed trait but not all of them? The Left has no answer to this question. All it can do is flail and argue that being transgender is somehow morally better than being transracial because the former is more trendy and societally approved. It is odd to hear the same people who a few weeks ago were arguing that the right to self-definition trumps all considerations now laying down conditions for it. Apparently Dolezal can’t claim “transracial” status because not enough people have “experienced” the condition and not enough doctors have recognized it as real. Dolezal could point out that these were some of the same objections raised at the beginning of the transgender movement. (Excerpt) Read more at spectator.org ...